spacer
home > pmps > autumn 2009 > in small doses
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

In Small Doses

 

Despite the current economic crisis, the drug development pipeline remains robust. There are 9,605 drugs being developed this year compared to 7,322 in 2005 and 5,995 in 2000, according to the Pharma R&D Annual Review, published in May 2009 (1). Clinical trials are a critical component of the drug development process, determining which drugs will be taken to market and generate revenue to compensate for the costly R&D cycle.

Due to smaller production volumes, lines used to produce drugs for clinical trial operations have always had distinct needs in terms of processing equipment. Additionally, a number of industry trends are altering the drug development landscape, and these changes are having important effects on clinical trial and pilot drug production. This article explores some of the developing needs of drug manufacturers, and how advanced sterile filling and finishing technologies, designed specifically for pilot production and clinical trial lines, are helping to solve some of these challenges.

NEW PLAYERS, NEW DRUGS, NEW DEMANDS

Drug R&D activities have traditionally been dominated by large multinational pharmaceutical companies (Big Pharma). Now the rising number of mid-size biotech and biopharmaceutical companies moving projects into clinical trials is affecting equipment demands.

While established players typically have existing clinical trial lines up and running, this is not the case for new entrants, who, as an alternative to building their own lines, often outsource operations to CROs. This is just one reason why the global CRO market is expected to grow by 14 per cent each year over the next three years, making contract research a $35 billion industry by 2013 according to a recent report from Business Insights (2). This growth has driven the need for new and improved filling and packaging machinery with increased flexibility.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Dieter Bandtel graduated in Industrial Engineering from the University of Applied Science in Aalen in 1984. He started working in the sales department of Bosch Packaging Technology in 1989. Since 1999, he has been responsible for product management of the Vials Liquid and Vials Dry businesses. Dieter is currently the project manager for the MHI 2020. He has been involved in market research and customer surveys conducted for the development of the MHI machine in order to meet the industry trends and market needs in clinical trials filling and packaging.
spacer
Dieter Bandtel
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

MedPharm’s CSO and University of Reading Professor co-author new book on dermal formulation development

MedPharm’s Chief Scientific Officer and Co-Founder, Professor Marc Brown and University of Reading’s Professor Adrian Williams have co-authored the new book: ‘The Art and Science of Dermal Formulation Development”. It is the latest addition to ‘Drugs and the Pharmaceutical Sciences’, a series of textbooks and monographs published by CRC Press.
More info >>

White Papers

What Your Clinical Study Design Reveals About Your Clinical Packaging Needs

PCI Pharma Services

As the cost and complexities of drug development increase, so do the challenges of global clinical trials. Today’s sponsors must be able to manage and coordinate multiple resources, processes, and locations with speed and accuracy to design effective and efficient clinical trials. Securing a stable supply chain to deal with the uncertainties of clinical trials is critical. One misstep can have a profound impact not only on the cost and time of your trial but also on its overall success.
More info >>

 
Industry Events

World Pharma Week 2019

17-20 June 2019, Seaport World Trade Center, Boston

World Pharma Week will bring together a unique and international mix of large and medium pharmaceutical and biotech companies, CROs, leading universities and clinical research institutions, emerging companies and tool providers—making it a perfect meeting-place to share experience, foster collaborations across industry and academia, and evaluate emerging technologies.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement